Paxlovid

(Note 2)

Nirmatrelvir and ritonavir

Approval Information

Brand NamePaxlovid

Generic NameNirmatrelvir and ritonavir

ApprovedFebruary 2022

Type(Note 2)

Review Reports

English Review Report

PDF · 285.69 KB

Japanese Review Report

PDF · 978.83 KB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database